Principal investigator D. Branch Moody, MD with Brigham and Women’s Hospital and Harvard University recently discussed another pathway of allergic contact dermatitis. In a recent study, Dr. Moody found that T cells can directly respond to non-peptidic...
Dermatitis
Category
Edesa Biotech Receives Approval to Proceed from FDA for Phase 2B Allergic Dermatitis Trial
Edesa Biotech reported that the U.S. FDA has notified the company that it may proceed with its clinical investigation of EB01 under development as a potential treatment for chronic allergic contact dermatitis. The FDA "safe to proceed" letter formally approves the...
Penn State Study Reveals Hidradenitis Suppurativa Increases Alopecia Risk
Researchers led by Penn State Milton S. Hersey Medical Center in Pennsylvania reported that a study investigating the relationship between Hidradenitis Suppurativa (HS) and alopecia areata in a U.S. sample reveal that those with HS had a significantly higher risk for...
New Regional Dermatoses Reported in Some Patients on Dupilumab
As reported in Jama Network, Stanford University School of Medicine and colleagues reported that a nearly 25% of a segment of adults with atopic dermatitis who were taking dupilumab developed new regional dermatoses appearing mostly on the face. Gefei Alex Zhu, MD of...
Colorado Team Raises Bar for Successful Management of Severe Atopic Dermatitis
As reported in Science Daily, a team of investigators from the University of Colorado College of Nursing at CU Anschutz Medical Campus and National Jewish Health has identified comprehensive guidelines for managing severe atopic dermatitis (AD), the most generic form...
University Hospitals Cleveland Research Develops Diagnostic Checklist for Generalized Dermatitis
As reported in Dovepress, University Hospitals Cleveland Medical Center and Case Western Reserve University developed a generalized dermatitis (defined as histological spongiotic dermatitis affecting more than three anatomical areas of the skin surface) checklist for...